Stockwatch: Pharmaceutical Fight Club
This article was originally published in Scrip
Executive Summary
Last week was a hard week for life science stocks comprising three down days in the middle of the week that made me wonder about early retirement followed by a strong enough recovery on Friday to entice me back into the office on Monday. Even if we are close to a bottom if not a recovery in biotechnology and pharmaceutical share prices, it doesn't help the sector ambiance that everyone seemed to be fighting each other last week.